Uterine papillary serous carcinoma evolves via a p53-driven pathway
- 1 December 1996
- journal article
- Published by Elsevier in Human Pathology
- Vol. 27 (12) , 1295-1300
- https://doi.org/10.1016/s0046-8177(96)90340-8
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Uterine Papillary Serous Carcinoma (UPSC): A Clinicopathologic Study of 30 CasesGynecologic Oncology, 1995
- Endometrial intraepithelial carcinoma: A distinctive lesion specifically associated with tumors displaying serous differentiationHuman Pathology, 1995
- Uterine papillary serous carcinoma. A clinical studyCancer, 1995
- Endometrial Carcinoma In Situ in Postmenopausal WomenThe American Journal of Surgical Pathology, 1995
- Uterine Papillary Serous Carcinoma: Patterns of Metastatic SpreadGynecologic Oncology, 1994
- Expression of EGFR, HER-2/neu, P53, and PCNA in Endometrioid, Serous Papillary, and Clear Cell Endometrial AdenocarcinomasGynecologic Oncology, 1994
- Immunocytochemical Analysis of Uterine Papillary Serous Carcinomas for Estrogen and Progesterone ReceptorsInternational Journal of Gynecological Pathology, 1994
- Uterine papillary serous carcinoma: A study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinomaGynecologic Oncology, 1992
- Uterine Serous Carcinoma A Morphologically Diverse Neoplasm With Unifying Clinicopathologic FeaturesThe American Journal of Surgical Pathology, 1992
- Uterine papillary serous carcinomaThe American Journal of Surgical Pathology, 1982